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Abstract
Purpose: To describe and characterize daily machine quality assurance (QA) for an
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MR‐guided radiotherapy (MRgRT) linac system, in addition to reporting a longitudinal assessment of the dosimetric and mechanical stability over a 7‐month period of
clinical operation.
Methods: Quality assurance procedures were developed to evaluate MR imaging/radiation isocenter, imaging and patient handling system, and linear accelerator stability. A longitudinal assessment was characterized for safety interlocks, laser and imaging isocenter
coincidence, imaging and radiation (RT) isocentricity, radiation dose rate and output,
couch motion, and MLC positioning. A cylindrical water phantom and an MR‐compatible
A1SL detector were utilized. MR and RT isocentricity and MLC positional accuracy was
quantiﬁed through dose measured with a 0.40 cm2 x 0.83 cm2 ﬁeld at each cardinal
angle. The relationship between detector response to MR/RT isocentricity and MLC positioning was established through introducing known errors in phantom position.
Results: Correlation was found between detector response and introduced positional error (N = 27) with coefﬁcients of determination of 0.9996 (IEC‐X), 0.9967
(IEC‐Y), 0.9968 (IEC‐Z) in each respective shift direction. The relationship between
dose (DoseMR/RT+MLC) and the vector magnitude of MLC and MR/RT positional error
(Errormag) was calculated to be a nonlinear response and resembled a quadratic function: DoseMR/RT+MLC[%] = −0.0253 Errormag [mm]2 − 0.0195 Errormag [mm]. For the
temporal assessment (N = 7 months), safety interlocks were functional. Laser coincidence to MR was within ±2.0 mm (99.6%) and ±1.0 mm (86.8%) over the 7‐month
assessment. IGRT position–reposition shifts were within ±2.0 mm (99.4%) and
±1.0 mm (92.4%). Output was within ±3% (99.4%). Mean MLC and MR/RT isocenter
accuracy was 1.6 mm, averaged across cardinal angles for the 7‐month period.
Conclusions: The linac and IGRT accuracy of an MR‐guided radiotherapy system
has been validated and monitored over seven months for daily QA. Longitudinal
assessment demonstrated a drift in dose rate, but temporal assessment of output,
MLC position, and isocentricity has been stable.
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1 | INTRODUCTION

ET AL.

characterized through introducing known errors and/or through comparing to established QA procedures. Lastly, we describe the ﬁrst

Image‐guided radiation therapy (IGRT) has enabled high accuracy

reporting of the longitudinal assessment of the dosimetric and

and precision of treatment delivery through the use of imaging per-

mechanical accuracy of a commercial MRgRT linac over a 7‐month

formed before and/or during treatment. Historically, on‐board imag-

period of clinical operation.

ing capabilities have been limited to kV and/or MV imaging
modalities. Recently, magnetic resonance imaging (MRI) has been
incorporated into radiotherapy treatment units with MR‐guided
radiotherapy (MRgRT) systems.
The emergence of MRgRT systems poses a new set of challenges

2 | MATERIALS AND METHODS
2.A | ViewRay MRIdian linac

when implementing existing quality assurance (QA) equipment and

The MRIdian linac, previously described by Hill and Mittauer, con-

procedures that have been utilized with x‐ray‐based IGRT systems.

sists of a gantry‐mounted 6 MV linear accelerator and a 0.345 T

Daily QA is performed on conventional linac accelerators utilizing

MRI scanner.2 The linac produces a 6‐MV ﬂattening ﬁlter free beam

either an on‐board imaging array or a detector array for convenient,

with a nominal dose rate of 600 MU/min. Beam collimation is

robust dosimetric veriﬁcation without the need of handling individual

achieved using the RayZR™ MLCs, consisting of a set of two banks

ionization chamber(s).1 A current commercial MRgRT linac (MRI-

of MLCs, stacked and double focused, and offset by one‐half leaf

dian™, ViewRay Inc., Cleveland, OH, USA) does not include an on‐

width, eliminating the need for MLC tongue and groove design.9

board, x‐ray‐based detector for dosimetric veriﬁcation. Additionally,

With a 90 cm SAD, the MLCs project to a maximum ﬁeld size of

no MR‐compatible detector arrays have been developed that are vis-

27.4 cm2 x 24.07 cm2 at isocenter with individual leaf width projec-

ible in MR imaging.

tions of 8.3 mm.

Another unique challenge of MRgRT is the ability to verify IGRT
isocenter coincidence to radiation isocenter. Since conventional linear
accelerators have a single on‐board detector that is compatible with

2.B | Overview of phantom and QA procedures

both imaging and radiation source, simple localization of a phantom

An MR‐compatible A1SL detector (active volume of 4.4 mm length

through the two modalities (i.e., MV/kV) is used to verify coincidence,

and 4 mm diameter) within a cylindrical water phantom (ViewRay

while MRgRT systems contain no such detector. Currently, no method

Inc., Cleveland, OH, USA) shown in Fig. 1 was utilized for this study.

of veriﬁcation of isocentricity has been reported in the literature. Cur-

The phantom is ﬁlled with distilled water to enable MR imaging

rent solutions to evaluate MR/RT isocentricity for MRgRT systems

capabilities. The phantom includes scribed locations for laser align-

have been practically carried out with ﬁlm enclosed by a water phan-

ment which are coincident with the centroid of the active volume of

tom using a star shot irradiation technique, eliminating real‐time infor-

the ionization chamber. There are four additional chamber positions

mation and impractical for a daily QA technique.2

located at the periphery of the cylindrical phantom. The phantom is

Daily QA guidance has been previously established for conven3–8

tional linear accelerators and MR imaging systems.

The daily QA

indexed to the table through two mounting brackets, with a cutout
for the posterior‐oriented torso receiver coils.

tests recommended in TG142, TG40, and MPPG 8a are designed to

An overview of the daily QA procedures is listed in Table 1, cat-

maintain safety, accurate patient localization, and dosimetric output

egorized by dosimetry, mechanical and imaging, and safety tests,

by monitoring parameters which can impact treatment goals.3,5,6

along with the applicable tolerance from TG142 based on SBRT/SRS

However, there is no existing literature or guidance for routine QA

speciﬁcations. A description of the QA method and the technique

on the two integrated systems to ensure consistent and safe opera-

used to characterize the method is also listed in Table 1.

tion and accurate treatment delivery using MRgRT.
In this study, we have developed and implemented an efﬁcient
and sensitive QA procedure to characterize the MR imaging/radiation

2.C | Safety functionality

isocenter alignment, spatial ﬁdelity of imaging and patient handling

Implemented safety checks include functionality of patient monitor-

systems, and the performance of the linear accelerator on an MRgRT

ing, radiation monitoring, beam interruption, and door interlocks.

system for routine daily QA. A method for real‐time characterization

Patient monitoring is veriﬁed for audio/visual communication devices,

of the MR/RT isocentricity is established through exploiting the sen-

including the panic bulb and audio headphones. Radiation monitoring

sitivity of the penumbra position across a large detector relative to

equipment, radiation interrupts, and interlocks are tested during

the ﬁeld size. As such, our method utilizes an MR‐compatible A1SL

beam delivery. The radiation area monitor and the control panel

detector (Standard Imaging Inc., Middleton, WI, USA) with an active

beam on indicator are visually conﬁrmed to be operational. Function-

volume of 4.4 mm length and 4 mm diameter placed within a cylin-

ality of the treatment vault door to prevent radiation generation

drical water phantom with a 0.40 cm x 0.83 cm ﬁeld size to opti-

with the door open and to interrupt radiation delivery of the beam

mize the spatial sensitivity of MR/RT isocentricity and MLC position.

when opened is independently veriﬁed. Additional door interlocks on

This work is the ﬁrst reporting of a daily QA procedure for an MR‐

the radiofrequency (RF) shielded doors designed to reduce RF inter-

guided radiotherapy system. The sensitivity of our methods has been

ference during imaging are veriﬁed to be operational.

2
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F I G . 1 . Cylindrical water phantom with
MR‐compatible A1SL ionization chamber
(left). Additional periphery ionization
chamber locations used as landmarks for
IGRT position–reposition evaluation (right).
Anterior‐positioned torso coil not pictured.

T A B L E 1 Overview of daily QA procedures, tolerances, technique, and characterization method.
Procedure

Tolerance

Description of technique

Method characterization

3%

10.04 cm2 x 9.96 cm2 ﬁeld output

TLD measurements and TG51

2%

10.04 cm x 9.96 cm ﬁeld MU/ time from UI

–

Laser and imaging isocentricity

1 mm

Daily QA phantom setup to scribe lines

Registration of phantom image

Radiation and imaging isocentricity

1 mm

0.40 cm2 x 0.83 cm2 ﬁeld dose at cardinal angles

Characterization of phantom shift vs. dose

Patient position–reposition accuracy

1 mm

Apply known shifts to phantom

Imaging of phantom landmarks

MLC positional accuracy

1 mm

0.40 cm x 0.83 cm ﬁeld dose at cardinal angles

Characterization of phantom shift vs. dose

Imaging coil functionality

Functional

–

–

Door interlocks

Functional

–

–

Radiation area monitor

Functional

–

–

Beam‐off/Radiation interrupt

Functional

–

–

In‐room camera

Functional

–

–

In‐room audio

Functional

–

–

Headphone audio

Functional

–

–

Panic bulb

Functional

–

–

Dosimetry
Output constancy
Dose rate constancy

2

2

Mechanical & imaging

2

2

Safety

2.D | MR spatial ﬁdelity and phantom localization

Postonline couch shifts for initial phantom localization, an IGRT
position–reposition test is performed in accordance with TG142.

The room lasers deﬁne a virtual isocenter located −155 cm in IEC‐Y

Here, a known shift is introduced of −0.75 cm (IEC‐X), −4.9 cm

direction from the MRIdian MR/RT isocenter. To verify that the

(IEC‐Y), and +0.75 cm (IEC‐Z), and the phantom is subsequently

lasers are coincident to this virtual isocenter, the phantom is initially

reimaged. Couch movement and geometric spatial ﬁdelity of the MR

aligned to the in‐room lasers using the external scribe marks, trans-

imaging is assessed using the known physical landmarks within the

lated +155 cm in the IEC‐Y direction, and then localized based on

phantom (Fig. 2). The image of the shifted phantom ideally places

MR imaging. A balanced steady‐state–free precession sequence

the edges of the peripheral chamber inserts in a known geometry.

(TrueFISP) MR scan is acquired in 65 s with a 1.5 mm3 x 1.5 mm3

Speciﬁcally, at the image volume origin, the IEC‐X landmark inter-

x 1.5 mm3 resolution over 45 cm3 x 23 cm3 x 26 cm3 ﬁeld of view

sects the edge of the sagittal plane in the axial view, and the IEC‐Z

for the daily setup MR scan and the simulation reference MR scan,

landmark intersects the edge of the coronal plane in the same axial

that is, the primary dataset used for the treatment plan generation.

view (Fig. 2). The IEC‐Y landmark is visually veriﬁed by identifying

Maximum spatial distortion of the MRIdian TrueFISP sequence is

the beginning of its edge on the superior‐adjacent axial slice (i.e.,

<1 mm within 5 cm of isocenter.10 Localization is then achieved

located 1.5 mm from isocenter in +IEC‐Y). Postvisual veriﬁcation of

through manual alignment of the chamber holder about the active

the positioning offset by known landmarks, the phantom is shifted

volume of interest for the A1SL ionization chamber. Phantom shifts

back to isocenter and reimaged. Sensitivity of the visual inspection

are recorded as the difference between laser and imaging isocenters

of the known offset is limited by the voxel resolution (1.5 mm iso-

for the IEC‐X, IEC‐Y, and IEC‐Z dimensions.

tropic). The phantom is localized again, and any residual registration
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of alignment for both the offset position and aligned position is

MLC positional accuracy at each cardinal gantry angle. This ﬁeld

taken as the error of the position–reposition localization.

size was selected to optimize spatial sensitivity with the A1SL
active volume (described above). Ionization values are converted

2.E | Dosimetry, MLC, and MR/RT isocentricity

to dose based on chamber and electrometer coefﬁcient and temperature and pressure values. Dose is monitored as the ratio with

Postphantom localization of the chamber active volume with

respect to baseline dose for each ﬁeld to eliminate reduction of

isocenter, a ﬁve‐ﬁeld 3D conformal treatment plan (Fig. 3) is deliv-

sensitivity from averaging across multiple gantry angles. To moni-

ﬁeld delivered

tor the linac constancy, dose rate is calculated as the delivered

with the gantry at zero degrees (G0, IEC 1217) to measure the

MU over the recorded delivery time from the UI of the treatment

dosimetric output and a 0.40 cm2 x 0.83 cm2 ﬁeld at each cardinal

planning and delivery system (TPDS) for the 10.04 cm2 x 9.96 cm2

angle characterizes the spatial accuracy of MR/RT isocentricity and

ﬁeld.

2

2

ered. The plan includes a 10.04 cm x 9.96 cm

F I G . 2 . IGRT position–reposition
alignment showing the phantom position
postcouch offsets applied. Veriﬁcation of
couch and IGRT positioning accuracy
performed with visualization of landmarks
using greyscale (image view) and inverse
greyscale image (positioning scan) values
with window = 1.

F I G . 3 . Dose distribution for ﬁve‐ﬁeld
3D conformal daily QA plan with
10.04 cm2 x 9.96 cm2 to measure the
dosimetric output and a
0.40 cm2 x 0.83 cm2 to characterize spatial
accuracy of MR/RT isocentricity and MLC
at each cardinal gantry angle. Active
volume of ionization chamber denoted as
region of interest.
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Reference dose was calculated using MRIdian's Monte Carlo
dose calculation algorithm with magnetic ﬁeld corrections, dose grid

31

isocenter. The relationship between dose and vector magnitude of
MLC and MR/RT positional error was quantiﬁed.

resolution of 2 mm3, and Monte Carlo uncertainty of 0.2%. Refer-

The dosimetric output using the daily QA procedure was bench-

ence dose was taken for each of the ﬁve 3D conformal ﬁelds for

marked by comparison to measurements performed with monthly

respective baseline values. Reference dose was reported as a point

QA using TG51 protocol in a water tank, in addition to an indepen-

of interest (POI) for 0.40 cm2 x 0.83 cm2 and a region of interest

dent output veriﬁcation through an Accredited Dosimetry Calibration

(ROI) approximating the active volume of the A1SL chamber for

Laboratory (ADCL) service with TLD irradiation.12 Here, six TLDs

10.04 cm x 9.96 cm . The POI was selected for small ﬁelds, due to

were irradiated on MRIdian under reference conditions with a dose

the limitation of TPS ROI delineation as whole voxel delineation. The

of 200 cGy at a depth of 10 cm, 90 cm SAD. The calibration TLDs

reference dose to POI was calculated several times to estimate

were irradiated on an independent system, TrueBeam STx (Varian

uncertainty due to random particle histories to the POI, dose dis-

Medical Solutions Inc., Palo Alto, CA, USA), with a known dose deliv-

crepancies were <0.28% between repeated calculations. Retrospec-

ered to the TLDs ranging from 180 to 220 cGy using the 6‐MV FFF

tively, the dose grid resolution was set to 1 mm3 to evaluate impact

beam to minimize spectral differences between the beams.

2

2

of 2 mm3 on the reference dose for the 0.40 cm2 x 0.83 cm2 ﬁelds,
dose discrepancies were <0.20% between the dose grid resolutions.

2.F | Characterization of methods

2.G | Longitudinal assessment
A longitudinal assessment of the daily QA performance on MRIdian
linac was evaluated over a 7‐month period (June 4, 2018 to January

The sensitivity of our methods has been characterized through intro-

12, 2019, N = 166 measurements). FileMaker Pro, a cross‐platform

ducing known errors and/or through comparing to established QA

database manager which allows for the creation of graphical user

procedures. The relationship between detector response to MR/RT

interfaces and forms for data input, was implemented to record the

isocentricity and MLC positioning was established through introduc-

daily QA results (Fig. 4). Functional tests were evaluated as a binary

ing known errors in phantom position to simulate offsets in MR/RT

pass–fail test. Quantitative data were recorded for laser and imaging

isocentricity and MLC position.

isocentricity, IGRT position–reposition, MR/RT isocentricity and MLC

The MLC positional accuracy and the MRI to RT isocentricity had

accuracy as measured by dose of 0.40 cm2 x 0.83 cm2 at each cardi-

been characterized on the institution's MRIdian, independent of the

nal angle, dose and dose rate for the 10.04 cm2 x 9.96 cm2. A one‐

methods utilized for this study. Speciﬁcally, a ﬁve‐ﬁeld star shot every

way ANOVA was used to determine if a statistical difference existed

72° of gantry rotation with radiochromic ﬁlm inserted into the cylindri-

across the relative output of the 0.40 cm2 x 0.83 cm2 ﬁeld size

cal phantom (IEC‐X and IEC‐Z displacement) and ﬁlm wrapped around

across the four cardinal angles in the longitudinal assessment.

the exterior of the cylindrical phantom (IEC‐Y displacement) demonstrated radiation coincidence to within 0.6 mm (radius) with phantom
alignment based on MR imaging at G0. Additionally, the MRI isocenter

3 | RESULTS

walkout as a function of gantry rotation was characterized through 3D
imaging of the cylindrical water phantom every 15° of gantry rotation

The sensitivity of the 0.40 cm2 x 0.83 cm2 ﬁeld (N = 27 introduced

and registering to the baseline image acquired at G0. The maximum

errors) is displayed in Fig. 5. Percentage difference in dose from

magnitude of vector displacement of isocenter was found to be

isocenter (DoseMR/RT+MLC) with respect to vector magnitude of

1.4 mm, and at the cardinal angles found to be have vector displace-

phantom positional error (i.e., surrogate of MLC and MR/RT posi-

ment of 1.1 mm (G90), 1.4 mm (G180), 1.0 mm (G270) with respect to

tional error) is quantiﬁed for a unidirectional positional error

the phantom localization at G0. MLC positional accuracy at central axis

[Fig. 5(a)–5(c)] for each cardinal angle and a positional error in two

and off axis was previously reported at our institution by Mittauer et al.

or more directions [Fig. 5(d)] averaged across all gantry angles with

using an ionization proﬁler and found to be within 0.06 ± 0.16 mm at

error bars representing ±1 SD.

baseline with no drift 0.00 ± 0.12 mm (n = 6 months) quantiﬁed using
half beam block at cardinal angles about the central axis.9
To characterize this study's methods of detector response to MR/

The relationship between dose (DoseMR/RT+MLC) and the MLC
and MR/RT positional error in IEC‐X [ErrorIEC‐X, eq. (1)], IEC‐Y [ErrorIEC‐Y, eq. (2)], and IEC‐Z [ErrorIEC‐Z,

eq. (3)] directions in addition to the

RT isocentricity and MLC positioning, a baseline measurement was

vector magnitude of MLC and MR/RT positional error [Errormag, eq.

ﬁrst established at each cardinal angle with the active volume of ion-

(4)] across all three directions was calculated to be a nonlinear

ization chamber centered with respect to isocenter, based on MRI. To

response and resembled a quadratic function:

simulate offset, the phantom was shifted in 1‐mm increments along
the IEC‐X, IEC‐Y, and IEC‐Z axes (IEC 1217 convention) independently
and dose delivered with the 0.40 cm2 x 0.83 cm2 ﬁeld was recorded

DoseMR=RTþMLC ½% ¼ 0:0677 ErrorIECX ½mm2
þ0:0119 ErrorIECX ½mm

(1)

for each shifted position.11 Simultaneous shifts in two or more directions were also reported. The dose measured from introduced shift
was normalized to the dose measured with the chamber positioned at

DoseMR=RTþMLC ½% ¼ 0:0308 ErrorIECY ½mm2
0:0042 ErrorIECY ½mm

(2)
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output was 0.992 ± 0.012 for daily QA and 0.997 ± 0.005 for
DoseMR=RTþMLC ½% ¼ 0:0780 ErrorIECZ ½mm2
þ0:0241 ErrorIECZ ½mm

monthly QA as measured by the TG51 protocol
(3)

The positional accuracy of the laser to MR imaging isocenter
coincidence is displayed as a histogram in Fig. 7 over the 7‐month
longitudinal assessment. Laser coincidence to MR was within

DoseMR=RTþMLC ½% ¼ 0:0253 Errormag ½mm2
0:0195 Errormag ½mm

(4)

2

The coefﬁcient of determination (R ) and root mean square error
(RMSE) are displayed in Fig. 5 for the respective equations. Note

±2.0 mm for 99.6% of all measurements and within ±1.0 mm for
86.8% of all measurements. The mean laser positional error to MR
imaging was −0.09 ± 0.56 mm (IEC‐X), −0.03 ± 0.58 mm (IEC‐Y),
and −0.15 ± 0.53 mm (IEC‐Z).

that the measurements for shifts in the gun‐target direction were

The IGRT and couch position–reposition accuracy is shown in

omitted from the quadratic ﬁt for unidirectional positional errors

Fig. 8. The position–reposition accuracy was 0.38 ± 0.52 mm (IEC‐X),

only, that is, IEC‐X and IEC‐Z [Fig. 5(a) and 5(c)].
Dosimetric output of the MRIdian linac for monthly QA (TG51
protocol in water tank), daily QA (cylindrical water phantom), and an

−0.25 ± 0.38 mm (IEC‐Y), and −0.11 ± 0.51 mm (IEC‐Z). IGRT position–reposition accuracy was within ±2.0 mm for 99.4% and
±1.0 mm for 92.4% of all measurements on the MRIdian linac.

independent output measurement (ADCL‐reported TLD irradiation)

The longitudinal assessment of dose rate of the MRIdian linac is

are displayed in Fig. 6 as a ratio of the measured dose to the

displayed in Fig. 9. A steady decrease, from 630 MU/min at initial

expected dose from calibration, 1 cGy/MU. The mean dose to the

installation to 545 MU/min in July 2018, prompted an adjustment in

TLDs reported by the ADCL at 0.992 ± 0.008 agreed with the insti-

the pulse repetition frequency (PRF) from 161 Hz to 183 Hz. Post‐

tutional measurements of TG51 monthly QA measurements at

PRF adjustment a decrease in dose rate continued to be observed

0.991, and the daily QA measurement at 0.992 measured on same

from the adjusted dose rate. A linear ﬁt to this portion of the data

date. The TLD measurement and the corresponding TG51 measure-

indicates a decrease in dose rate of 0.58 MU/min/day (R2 = 0.974).

ment on the same day were within 0.95% of the expected 1 cGy/

To evaluate the spatial accuracy of the MLC and MR/RT isocen-

MU, and the corresponding daily QA measurement was within

tricity of the MRIdian linac, the dosimetric change for a 0.40 cm2

0.80%. The mean difference between all TG51 and daily QA mea-

x 0.83 cm2 ﬁeld at each cardinal gantry angle is displayed in Fig. 10

surements on days when both measurements were performed

as a box plot. The average and standard deviation of the ratio of

(N = 7) was 0.008 ± 0.01.

measured to reference dose was 0.95 ± 0.05 (G0), 0.87 ± 0.06

Figure 6 also displays the longitudinal performance of the MRI-

(G90), 0.90 ± 0.05 (G180), and 0.90 ± 0.05 (G270). Solving the equa-

dian output over the seven months. The mean deviation in linac

tion from the ﬁt of vector magnitude positional shifts in Fig. 5(d),

FIG. 4.

Institutional data record for MRIdian daily QA electronic database, utilizing the FileMaker Pro application.
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F I G . 5 . The relationship between dose
(DoseMR/RT+MLC) and the MLC and MR/RT
positional error in IEC‐X (ErrorIEC‐X, a), IEC‐
Y (ErrorIEC‐Y, B), and IEC‐Z (ErrorIEC‐Z, C)
directions in addition to the vector
magnitude of MLC and MR/RT positional
error (Errormag, D) across all three
directions.

F I G . 6 . Comparison of dosimetric output stability for monthly QA
(TG51 protocol in water tank), daily QA (cylindrical water phantom),
and an independent output measurement (ADCL‐reported TLD
irradiation).

F I G . 7 . Histogram of longitudinal assessment of laser positional
accuracy to MR isocenter coincidence.

the mean MR/RT and MLC positional error of the MRIdian linac was

attributed to small changes in radiation isocenter or gravity‐induced

1.1 mm (G0), 1.9 mm (G90), 1.6 mm (G180), and 1.6 mm (G270)

MLC effects with gantry rotation.

over the 7‐month longitudinal assessment. There is a statistical difference (p < 0.001) observed among the four cardinal angles, likely

All safety QA procedures found in Table 1 passed functionality
on a daily basis over the longitudinal assessment.
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F I G . 8 . Histogram (left) and line plot
(right) of IGRT and couch position–
reposition accuracy.

combined with real‐time tracking capabilities has enabled greater
conﬁdence in the treatment delivery allowing for a reduction in the
planning target margin compared to CT‐based IGRT modalities.13
However, the temporal assessment of a clinical MRgRT system or
implementation of daily QA has yet to be reported. Current commercial daily QA equipment and guidance criteria are limited to CT‐
based IGRT modalities may not be applicable to MRgRT systems due
to equipment incompatibility in a magnetic ﬁeld and/or fundamental
differences in the clinical utility of the technology. In this study, we
describe a novel daily QA procedure that exploits the spatial sensitivity of the penumbra to evaluate the MLC positional accuracy and
MR/RT isocentricity for an efﬁcient, robust daily QA procedure. In
addition, we report the ﬁrst evaluation of the longitudinal assessment of a clinical MRgRT linac system in terms of IGRT spatial ﬁdeF I G . 9 . Longitudinal dose rate performance of the MRIdian linac
with PRF adjustment performed on June 23, 2018.

lity and linac integrity.
Our technique has allowed TG142 criteria to be applicable and
quantiﬁed on a daily basis. Currently, no guidance has been established for best practices and/or tolerances for routine QA of clinical
MRgRT systems. For our evaluation, we applied TG142 tolerances
for CT‐based IGRT systems where applicable. Daily QA techniques
on CT‐based modalities often employ on‐board imaging systems.1,14
However, the implementation of x‐ray‐based detectors may not be
applicable to MRgRT with some commercial MRgRT systems not
having an onboard x‐ray detector (i.e., MRIdian), therefore an external array or ionization chamber is necessary. Our technique has
employed one phantom in combination with a single ionization
chamber. However, care must be taken with daily handling of an ionization chamber and triaxial cable.
Implementation of the daily output was benchmarked by comparing two independent procedures: TG51 protocol in water tank,
and TLD service reported by the ADCL. The output as measured
with daily QA procedure was in line with both TG51 procedure, and

F I G . 1 0 . MR/RT isocentricity and MLC positional accuracy of the
MRIdian linac for 0.40 cm2 x 0.83 cm2 ﬁeld at cardinal gantry angles
over longitudinal evaluation.

4 | DISCUSSION

the independent TLD readings within 0.15%. Overall dosimetric output of the MRIdian linac was very stable over the ﬁrst 7 months of
clinical use and within tolerance of TG142 criteria of 3% for 99.4%
of daily measurements (Fig. 6). Small ﬂuctuations may be attributed
to the machine and/or chamber and electrometer not fully warmed
up prior to output measurement.

The clinical efﬁcacy of MR guidance has previously been shown by

One observed drift over the temporal assessment of the MRIdian

the MRgRT community.13 The superior soft tissue visualization

linac was a systematic decrease in dose rate from time of initial
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installation (Fig. 9). The dose rate was intentionally increased in July

sequence. We used the highest available resolution at 1.5 mm3 x 1.5

2018 through changing the PRF from 161 Hz to 183 Hz. The

mm3 x 1.5 mm3. Due to volume averaging across voxels and gantry

increase of PRF was noted to have a small increase in the linac dark

dependency of the MRI, some resulting deviations were greater than

current, which continues to be monitored on a monthly basis.

1 mm, however, 99.4% of measurements remained less than 2 mm.

The MR/RT isocentricity and MLC positional accuracy as mea-

This approach of setting the gantry angle during MR imaging to a

sured with 0.40 cm2 x 0.83 cm2 ﬁeld at each cardinal angle was

speciﬁed location to minimize MR/RT isocentricity has been imple-

benchmarked for sensitivity through introducing known errors across

mented clinically at our institution for the initial 3D volumetric scan

IEC‐X, IEC‐Y, IEC‐Z for each cardinal angle (Fig. 5). As such, imple-

for MRgRT patient setup and simulation images.15 For IGRT posi-

mentation of this small ﬁeld allowed for characterization of not only

tion–reposition accuracy, a greater drift was noted at 10/2018 to 01/

shifts due to MR/RT offset but also MLC positional error as a func-

2019 (Fig. 8), likely attributed to interuser dependence of phantom

tion of gantry angle. The overall sensitivity was found to be 5.6%

localization, as timepoint corresponds to a rotation of operator.

(1 mm) and 24.7% (2 mm) for IEC‐X [Fig. 5(a)], 3.5% (1 mm) and

Although not performed for this study, mitigation of MRI gantry

13.2% (2 mm) for IEC‐Y [Fig. 5(b)], and 5.4% (1 mm) and 26.4%

dependence can be performed through 3D volumetric imaging at the

(2 mm) for IEC‐Z [Fig. 5(c)] for unidirectional errors and 4.5% (1 mm)

optimal gantry angle in which the centroid of MR isocenter is equal

and 14.0% (2 mm) for the vector magnitude of error [Fig. 5(d)]. Shifts

to the centroid of RT isocenter. Such an approach has been imple-

along the gun‐target direction were relatively insensitive due to neg-

mented clinically for the initial 3D volumetric scan for MRgRT setup

ligible change in photon ﬂuence as a function of inverse square of

and simulation images at our institution.

small distance changed from the source to detector [Fig. 5(a), G90

Additional unique considerations for MRgRT systems include

and G270; Fig. 5(c), G0 and G180]. The IEC‐X and IEC‐Z directions

ﬁdelity of the MR imaging system, that is, spatial integrity and over-

[Fig. 5(a) and 5(c)] were found to be more sensitive in comparison to

all functionality of the MRI scanner. Veriﬁcation of the absence of

the IEX‐Y direction [Fig. 5(b)]. This was due to the resolution of ﬁeld

any ferromagnetic objects being lodged in the MRI scanner and com-

size is limited by MLC leaf width (i.e., 4.15 mm) across the IEC‐Y

munication between the MRI scanner and radiotherapy user inter-

direction. The ﬁeld size in IEC‐Y direction was selected as 8.3 mm to

face are necessary components of the daily QA. Through our

allow for symmetric evaluation about isocenter, as the MRIdian cen-

implemented technique, the daily QA serves as an end‐to‐end proce-

tral leaves of 4.15 mm are split above and below isocenter with

dure in the clinical treatment workﬂow, therefore enabling evalua-

respect to IEC‐Y. Therefore, the IEC‐Y ﬁeld length (8.3 mm) is larger

tion that the TPDS and MRI scanner are communicating in the

than the active length (4.4 mm) leading to the observed reduction in

clinical state. An additional consideration with regard to the overall

sensitivity. For the multidirectional shifts [Fig. 5(d)], the overall

health of the MRI scanner is the integrity of the MRI receiver coils.

reduction in sensitivity and larger error bars at 1 and 2 mm are due

At our institution a weekly procedure to verify the signal to noise

to the inclusion of points which are shifted in the gun‐target direc-

(SNR) and percentage integral uniformity for coil integrity is per-

tion.

formed. One could easily incorporate coil robustness by measuring

The relationship between MR/RT offset and MLC position error
to detector dosimetric difference was characterized and correlated

the SNR over the uniform water areas of the phantom for the daily
QA procedure.

well with R2 = 0.99. One limitation of the technique is that MLC,

A limitation of our technique is that the real‐time tracking and

MR/RT isocentricity, and dosimetric output are not decoupled. The

online adaptive components are not incorporated. Both mechanisms

dosimetric output could easily be decoupled by normalizing the

are likely low failure frequency as has been demonstrated over insti-

2

2

0.40 cm x 0.83 cm

result by the daily dosimetric constancy

tutional practice and QA. Nonetheless, QA of these components

acquired at 10.04 cm2 x 9.96 cm2. For the longitudinal assessment

should be established in a routine QA program. One practical

of MR/RT isocentricity and MLC accuracy, the impact of dosimetric

method to verify treatment planning system integrity for online

uncertainty can be considered negligible as the output constancy for

adaptive planning is incorporating a checksum to identify uninten-

the 10.04 cm2 x 9.96 cm2 ﬁeld was stable at 0.992 ± 0.012.

tional modiﬁcations to system conﬁgurations and database con-

Our MLC positional accuracy is in agreeance to our institutional
9

tents.4,16 Detailed account of an end‐to‐end validation of online

weekly QA MLC positional reproducibility. Small MLC gravitational‐

adaptive radiotherapy has been previously described by Mittauer

induced effects combined with isocenter dependency with gantry

et al. for an MRgRT program.17 Quality assurance of the gating capa-

rotation are observed, and are ampliﬁed due to the high sensitivity

bilities of the MRIdian can be monitored with an end‐to‐end proce-

2

2

of the small‐ﬁeld (i.e., 0.40 cm x 0.83 cm ) daily QA procedure. Our
9

dure with a motion phantom as described by Lamb et al.18

weekly MLC QA is performed for each MLC bank evaluated inde-

Although not part of TG142 criteria for daily QA, a limitation of

pendently. A similar technique could be employed for the daily QA

our technique is that energy is not veriﬁed on a daily basis. One

in which the four cardinal angles are measured twice for each upper

method to incorporate an energy check into the existing phantom

and lower MLC bank, (i.e., MLC1 and MLC2) to allow for bank differ-

design is to add a second ionization chamber at the IEC‐X landmark,

ences to be uniquely determined.

that is, chamber holder. Here, the ratio of the distal chamber to the

A limitation of the sensitivity of MR/lasers and IGRT positioning
and repositioning evaluation is the spatial resolution of the imaging

central chamber for the 10.04 cm2 x 9.96 cm2 ﬁeld at G0 could be
evaluated as a surrogate for energy constancy.
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5 | CONCLUSION
The linac and IGRT accuracy of a MR‐guided radiotherapy linac system
been validated and monitored over seven months with an efﬁcient,
highly sensitive and robust method for routine QA. Longitudinal
assessment demonstrated a drift in dose rate, but temporal assessment of output, MLC position, and isocentricity has been stable.
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